MOESM7 of BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity

Additional file 7: Table S4. Table of DESeq2 differential binding (DB) results for all TSSs in MV4;11. TSSs are represented by their gene name followed by the Refseq ID in the form name_REFSEQ_ID. This nomenclature allows us to differentiate between TSSs belonging to different transcripts of the same gene. Column names contain the information on the protein (BRD4) and the inhibitor concentration, i.e., mb4_50_1 Kb_Up.log2FoldChange corresponds to the log2 fold change of the DB analysis on MV4;11 (m), for the protein BRD4 (b4) at 50 nM of inhibitor (50) for TSS − 1 Kb (1 Kb_UP).

附加文件7：表S4。本表格为MV4;11细胞中所有转录起始位点（Transcription Start Site, TSS）的DESeq2差异结合（Differential Binding, DB）分析结果表。每条转录起始位点以基因名后接Refseq编号的形式标注，格式为`name_REFSEQ_ID`。该命名规则可用于区分同一基因不同转录本对应的转录起始位点。列名包含靶蛋白（BRD4）与抑制剂浓度相关信息，例如`mb4_50_1 Kb_Up.log2FoldChange`对应的是：以MV4;11细胞（m）为分析样本、靶蛋白BRD4（b4）、抑制剂浓度为50 nM（50）、转录起始位点位于-1kb上游区域（1 Kb_UP）的差异结合分析的log2倍变化值。